Novo Nordisk (NVO), the maker of the popular diabetes and weight-loss drugs Ozempic and Wegovy, expects at least some ...

While attention has been on Apple’s progress (or lack thereof) in Research Triangle Park, the company continues to spend on a ...

The entrance to one of Novo Nordisk’s two manufacturing facilities in Clayton, North Carolina on June 24, 2024. Brian Gordon [email protected] ...

Novo Nordisk (NVO) is not concerned by the ongoing US trade war and the 25% tariff set to go into effect for pharmaceutical ...

Novo Nordisk's semaglutide ... of two new facilities in the US and Denmark. One of these, at Clayton in North Carolina, will focus on producing active pharmaceutical ingredients (APIs) for ...

Eli Lilly has invested $5.3 billion to expand manufacturing capacity, while Novo Nordisk is building a $4.1 billion fill-finish plant in Clayton, North Carolina. However, these expansions take ...

Novo Nordisk's $1.8B expansion in Clayton is the single largest manufacturing investment ... headquartered outside the United States started or expanded operations in North Carolina during the last 12 ...

Wegovy's maker, Novo Nordisk, is charging $499 per month for its direct-to ... has made it difficult for health insurance plans to cover them. For example, in North Carolina, the state health plan ...

Novo Nordisk stock has fallen roughly 40% from a peak it reached last June. The U.S. Food and Drug Administration recently confirmed Novo Nordisk is producing enough Ozempic and Wegovy to meet demand.